SCHEMBL9702900

SCHEMBL9702900

CN(C)CCCNC(=O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.54
DNM1 Q05193 1/20 0.50
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.45
PAOX Q6QHF9 1/20 0.44
HPGD P15428 1/20 0.44
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
P2RX4 Q99571 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78355 0.89 KDM4E (0.59) KDM4EDNM1LMNAPOLBPAOX
SCHEMBL9702686 0.86 DNM1 (0.46) KDM4EDNM1ALDH1A1MEN1HTT
Hydrochloric Acid SCHEMBL10442360 0.84 DNM1 (0.44) KDM4EDNM1ALDH1A1MEN1HTT
Methacrylic Acid SCHEMBL452014 0.83 KDM4E (0.51) KDM4EDNM1LMNAPOLBPAOX
SCHEMBL17165990 0.83 KDM4E (0.59) KDM4EDNM1LMNAPOLBPAOX
SCHEMBL794226 0.82 DNM1 (0.53) KDM4EDNM1LMNAPOLBPAOX
SCHEMBL1245538 0.81 KDM4E (0.53) KDM4EDNM1LMNAPOLBPAOX
Acetic Acid SCHEMBL9438497 0.80 KDM4E (0.53) KDM4EDNM1LMNAPOLBPAOX
Bicarbonate SCHEMBL9017530 0.80 KDM4E (0.53) KDM4EDNM1LMNAPOLBPAOX
Hydrochloric Acid SCHEMBL793323 0.80 DNM1 (0.52) KDM4EDNM1PAOXHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5132454-A Antihypoxic agents MEIJI SEIKA KAISHA, LTD. (JP) 1992-07-21 US disclosed
US-5066677-A Antihypoxic agents, treatment of disorders resulting from reduced oxygen supply to brain MEIJI SEIKA KAISHA, LTD. (JP) 1991-11-19 US disclosed
EP-0387074-A2 Novel oxamic acid compounds and pharmaceutical composition for use in improvement of damaged cerebral functions of brain MEIJI SEIKA KAISHA LTD. (JP) 1990-09-12 EP disclosed